KPMG in Bulgaria performed a market study and outlined the characteristics of the clinical trials sector in the country.
Clinical trials in Bulgaria: KPMG study of the key challenges
Some insights are:
To delve into further detail, read the Executive Summary (available in English (PDF 401KB) and Bulgarian (PDF 469KB)) of KPMG’s study of the key challenges facing the clinical trials industry in Bulgaria.
About the study
KPMG in Bulgaria conducted the study of the clinical trials sector in Bulgaria upon the request of the Board of Directors of the Bulgarian Association of Clinical Research. The study is based on the responses to the questionnaire KPMG compiled to explore the views on the topic of pharmaceutical companies and clinical research organisations.
It further explores a selection of factors which have a substantial influence on the development of the clinical trials industry globally and locally and assesses select benefits and risks related to conducting clinical trials in Bulgaria.